Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.
Clinical trial NCT00328627 · COMPLETED
Trial details
- NCT number
- NCT00328627
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2008-03-01
- Enrollment
- 1554
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.